rs10492477

Variant summary

Our verdict is Benign.
<-10 Benign
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received -12 classification points (ACMG Germline Pathogenicity v2019). BA1BP4_Strong

The NM_203487.3(PCDH9):c.3138+135899T>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a cumulative frequency of 0.0813 (AC=12,363) in the gnomAD database across 152,066 control chromosomes, including 524 homozygotes. The grpmax filtering allele frequency (95% CI) is 0.131. In-silico predictor (BayesDel (noAF)) classifies this variant as likely benign. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.081 ( 524 hom., cov: 32)

Consequence

PCDH9
NM_203487.3 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.492

Publications

2 publications found
Variant links:
Genes affected
PCDH9 (HGNC:8661): (protocadherin 9) This gene encodes a member of the protocadherin family, and cadherin superfamily, of transmembrane proteins containing cadherin domains. These proteins mediate cell adhesion in neural tissues in the presence of calcium. The encoded protein may be involved in signaling at neuronal synaptic junctions. Sharing a characteristic with other protocadherin genes, this gene has a notably large exon that encodes multiple cadherin domains and a transmembrane region. Alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. [provided by RefSeq, Nov 2012]

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_203487.3, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACMG Germline Pathogenicity v2019

Classification was made for transcript

Our verdict: Benign. The variant received -12 points.

BP4
Computational evidence supports benign — no pathogenic computational or splicing signal (BP4); Splicing verdict: benign (Strong).; Germline computational verdict: benign (Strong).
BA1
GnomAD effective popmax AF >5% — BA1 stand-alone benign; GnomAD reliable popmax AF = 0.1310 — exceeds 5%% threshold (BA1 applied)

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_203487.3. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PCDH9
NM_203487.3
MANE Select
c.3138+135899T>A
intron
N/ANP_982354.1Q9HC56-1
PCDH9
NM_020403.5
c.3037-136194T>A
intron
N/ANP_065136.1Q9HC56-2
PCDH9
NM_001318372.2
c.3138+135899T>A
intron
N/ANP_001305301.1B7ZM79

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PCDH9
ENST00000377865.7
TSL:1 MANE Select
c.3138+135899T>A
intron
N/AENSP00000367096.2Q9HC56-1
PCDH9
ENST00000544246.5
TSL:1
c.3037-136194T>A
intron
N/AENSP00000442186.2Q9HC56-2
PCDH9
ENST00000456367.5
TSL:1
c.3138+135899T>A
intron
N/AENSP00000401699.2A0A0A0MST3

Frequencies

GnomAD3 genomes
AF:
0.0814
AC:
12362
AN:
151948
Hom.:
523
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0753
Gnomad AMI
AF:
0.0285
Gnomad AMR
AF:
0.0565
Gnomad ASJ
AF:
0.0730
Gnomad EAS
AF:
0.140
Gnomad SAS
AF:
0.0752
Gnomad FIN
AF:
0.0753
Gnomad MID
AF:
0.0475
Gnomad NFE
AF:
0.0886
Gnomad OTH
AF:
0.0882
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0813
AC:
12363
AN:
152066
Hom.:
524
Cov.:
32
AF XY:
0.0818
AC XY:
6080
AN XY:
74340
show subpopulations
African (AFR)
AF:
0.0752
AC:
3123
AN:
41516
American (AMR)
AF:
0.0564
AC:
860
AN:
15256
Ashkenazi Jewish (ASJ)
AF:
0.0730
AC:
253
AN:
3468
East Asian (EAS)
AF:
0.139
AC:
719
AN:
5156
South Asian (SAS)
AF:
0.0755
AC:
364
AN:
4820
European-Finnish (FIN)
AF:
0.0753
AC:
799
AN:
10604
Middle Eastern (MID)
AF:
0.0476
AC:
14
AN:
294
European-Non Finnish (NFE)
AF:
0.0886
AC:
6021
AN:
67932
Other (OTH)
AF:
0.0873
AC:
184
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
573
1146
1718
2291
2864
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
146
292
438
584
730
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0881
Hom.:
72
Bravo
AF:
0.0789
Asia WGS
AF:
0.121
AC:
423
AN:
3468

Local populations

Turkish Variome
AF:
0.0718
AC:
111
AN:
1546
Hom.:
6
ABraOM SABE-WGS-1171
AF:
0.0730
AC:
171
AN:
2342
Hom.:
6

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.59
CADD
Benign
16
DANN
Benign
0.91
PhyloP100
0.49
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.